Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M344Revenue $M39.8Net Margin (%)-275.6Altman Z-Score-5.9
Enterprise Value $M229EPS $-0.5Operating Margin %-261.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-275.6Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %-29.4Quick Ratio4.0Cash flow > EarningsY
Price/Sales8.45-y EBITDA Growth Rate %-45.7Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-35.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-123.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M243ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARNAKen Fisher 2015-12-31 Add$1.7 - $2.4
($2.04)
$ 1.42-30%Add 0.91%11,100
ARNAKen Fisher 2013-12-31 Buy $4.08 - $6.66
($5.22)
$ 1.42-73%New holding11,000
ARNAMario Gabelli 2011-03-31 Sold Out $1.41 - $2.16
($1.7)
$ 1.42-16%Sold Out0
ARNAMario Gabelli 2010-12-31 Buy $1.27 - $2.38
($1.58)
$ 1.42-10%New holding13,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARNA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-67.04view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-70.4view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-76.36view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-73.04view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-74.7view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-74.7view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-79.01view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-78.86view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-76.55view
Nova Tina SusanDirector 2014-04-14Sell35,000$6.22-76.21view

Quarterly/Annual Reports about ARNA:

    News about ARNA:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
    WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
    WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
    Arena Facing Increased Pressure from Peers Apr 23 2012 
    Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
    Vivus Could Rocket on Success of Qnexa Apr 13 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    Arena Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
    Arena Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2010 

    More From Other Websites
    Biotechnology Stocks Technical Review -- MannKind, Array BioPharma, Arena Pharma, and Chimerix Feb 08 2016
    Former US president Jimmy Carter Says His Brain Cancer Has Disappeared Jan 20 2016
    Bioelectronic-Medicine Leader Endonovo Therapeutics, Inc. Begins 2016 on a Strong Note Jan 19 2016
    AMD and Key Industry Partners Welcome the AMD Opteron(TM) A1100 SoC to the 64-Bit ARM Datacenter... Jan 14 2016
    Arena, Boehringer Ingelheim Ink Deal, Schizophrenia in Focus Jan 13 2016
    [$$] Arena Pharma Shares Rise on Collaboration Pact With Boehringer Jan 12 2016
    ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jan 12 2016
    Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia Jan 12 2016
    Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia Jan 12 2016
    This Company is Up +400% in a Month Jan 07 2016
    Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
    CEL-SCI Corp (CVM) Shows Strength: Stock Moves Up 8.3% Jan 07 2016
    Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
    Introducing T-Mobile Arena in Las Vegas Jan 07 2016
    Biotechnology Equity Picks - Arena Pharma, uniQure, Cytokinetics, and Curis Jan 06 2016
    Pluristem Therapeutics (PSTI) in Focus: Stock Rises 14.1% Jan 04 2016
    Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 30,... Dec 30 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK